검증된 단계별 안내
05:05
09:49
06:04An attribute of growth behavior of eight bacteriophage mutants (1 to 8) is investigated in experiments that establish coinfection by pairs of mutants. The experiments determine whether the mutants complement one another (+) or fail to complement (-). These eight mutants are known to result from point mutation. The results of the complementation tests are shown below.
How many genes are represented by these mutations?
An attribute of growth behavior of eight bacteriophage mutants (1 to 8) is investigated in experiments that establish coinfection by pairs of mutants. The experiments determine whether the mutants complement one another (+) or fail to complement (-). These eight mutants are known to result from point mutation. The results of the complementation tests are shown below.
New mutation 10 fails to complement mutants 1, 4, 5, 6, 8, and 9. Mutant 10 forms wild-type recombinants with mutants 1, 5, and 6, but not with mutants 4 and 8. Mutant 9 and mutant 10 form wild-type recombinants. What kind of mutation is mutant 10? Explain your reasoning.
An attribute of growth behavior of eight bacteriophage mutants (1 to 8) is investigated in experiments that establish coinfection by pairs of mutants. The experiments determine whether the mutants complement one another (+) or fail to complement (-). These eight mutants are known to result from point mutation. The results of the complementation tests are shown below.
A new mutation, designated 9, fails to complement mutants 1, 3, 5, 7, and 8. Wild-type recombinants form between mutant 9 and mutations 3, 5, and 8; however, no wild-type recombinants form between mutant 9 and mutations 1 and 7. What kind of mutation is mutant 9? Explain your reasoning.
Penicillin was first used in the 1940s to treat gonorrhea infections produced by the bacterium Neisseria gonorrhoeae. In 1984, according to the CDC, fewer than 1% of gonorrhea infections were caused by penicillin-resistant N. gonorrhoeae. By 1990, more than 10% of cases were penicillin-resistant, and a few years later the level of resistance was at greater than 95%. Almost every year the CDC issues new treatment guidelines for gonorrhea that identify the recommended antibiotic drugs and dosages.
What are the short-term implications of these frequent changes for physicians and clinics that treat sexually transmitted diseases like gonorrhea and for individuals infected with gonorrhea?
Penicillin was first used in the 1940s to treat gonorrhea infections produced by the bacterium Neisseria gonorrhoeae. In 1984, according to the CDC, fewer than 1% of gonorrhea infections were caused by penicillin-resistant N. gonorrhoeae. By 1990, more than 10% of cases were penicillin-resistant, and a few years later the level of resistance was at greater than 95%. Almost every year the CDC issues new treatment guidelines for gonorrhea that identify the recommended antibiotic drugs and dosages.
What are the long-term implications of these frequent changes in treatment recommendations for the patient population?
An attribute of growth behavior of eight bacteriophage mutants (1 to 8) is investigated in experiments that establish coinfection by pairs of mutants. The experiments determine whether the mutants complement one another (+) or fail to complement (-). These eight mutants are known to result from point mutation. The results of the complementation tests are shown below.
In each coinfection identified as a failure to complement (−) in the table, researchers see evidence of recombination producing wild-type growth. How do the researchers distinguish between wild-type growth resulting from complementation and wild-type growth that is due to recombination?
